A neuropeptide with diverse biological activities
货号:ajcx21090
CAS:N/A
分子式:C20H32D4O5
分子量：360.5
溶解度:DMF: 50 mg/ml,DMSO: 50 mg/ml,Ethanol: 50 mg/ml,PBS (pH 7.2): 1 mg/ml
纯度：98%
存储：Store at -20°C
库存：现货

Background:

13,14-dihydro Prostaglandin E₁-d₄(13,14-dh PGE₁-d₄) contains four deuterium atoms at the 3, 3', 4, and 4' positions. It is intended for use as an internal standard for the quantification of 13,14-dh PGE₁by GC-or LC-mass spectrometry. 13,14-dh PGE₁is an inhibitor of ADP-induced platelet aggregation in human platelet-rich plasma and washed platelets with IC₅₀values of 31 and 21 nM, respectively.¹13,14-dh PGE₁is a slightly more potent inhibitor of ADP-induced human platelet aggregation than PGE₁which has an IC₅₀of 40 nM.²Also, 13,14-dh PGE₁activates adenylate cyclase in NCB-20 hybrid cells with a Kact of 668 nM.³

1.Kobzar, G., Mardla, V., JÄrving, I., et al.Comparison of the inhibitory effect of E-prostaglandins in human and rabbit platelet-rich plasma and washed plateletsComparative Biochemistry and Physiology106(2)489-494(1993) 2.Kobzar, G., Mardla, V., JÄrving, I., et al.Antiaggregating potency of E-type prostaglandins in human and rabbit plateletsProceedings of the Estonian Academy of Sciences.Chemistry40179-180(1991) 3.Blair, I.A., Hensby, C.N., and MacDermot, J.Prostacyclin-dependent activation of adenylate cyclase in a neuronal somatic cell hybrid: Prostanoid structure-activity relationshipsBr. J. Pharmac.69(3)519-525(1980)